SELLAS Life Sciences (SLS) Treasury Shares (2010 - 2026)
SELLAS Life Sciences' (SLS) quarterly Treasury Shares came in at $3.8 million in Q3 2017, little changed year-on-year from $3.8 million in Q3 2016, and little changed on a QoQ basis from $3.8 million in Q2 2017.
SELLAS Life Sciences (SLS) Treasury Shares (2010 - 2026) Analysis & Trends
SELLAS Life Sciences (SLS) has 8 years of Treasury Shares data on file, last reported at $3.8 million in Q3 2017.
- On a quarterly basis, Treasury Shares changed 0.0% year-over-year to $3.8 million in Q3 2017; TTM through Sep 2017 was $3.8 million, a 0.0% change from a year earlier, with the FY2016 full-year figure at $3.8 million, changed 0.0% from the prior year.
- Treasury Shares for Q3 2017 stood at $3.8 million, roughly flat from $3.8 million in the prior quarter.
- Over the last five years, Treasury Shares for SLS reached as high as $2.3 million in Q1 2026 and fell as low as $255000.0 in Q4 2022.
- Historically, Treasury Shares has averaged $799411.8 across 5 years, with a median of $472000.0 in 2024.
- On a YoY basis, Treasury Shares climbed as much as 0.0% in 2013 and fell as far as 0.0% in 2013.
- Year by year, Treasury Shares stood at $3.8 million in 2013, then changed by 0.0% to $3.8 million in 2014, then changed by 0.0% to $3.8 million in 2015, then changed by 0.0% to $3.8 million in 2016, then changed by 0.0% to $3.8 million in 2017.
- Per Business Quant data, the three most recent Treasury Shares figures were $3.8 million in Q3 2017, $3.8 million in Q2 2017, and $3.8 million in Q1 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | SELLAS Life Sciences | 3.23 Mn | 3.23 Mn | - | 2.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.26 Mn |
| Mar 31, 2026 | 2.26 Mn |
| Dec 31, 2025 | 897,000.00 |
| Dec 31, 2025 | 897,000.00 |
| Sep 30, 2025 | 1.71 Mn |
| Sep 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Dec 31, 2024 | 472,000.00 |
| Dec 31, 2024 | 472,000.00 |
| Sep 30, 2024 | 644,000.00 |
| Sep 30, 2024 | 644,000.00 |
| Jun 30, 2024 | 644,000.00 |
| Jun 30, 2024 | 644,000.00 |
| Mar 31, 2024 | 738,000.00 |
| Mar 31, 2024 | 738,000.00 |
| Dec 31, 2023 | 338,000.00 |
| Dec 31, 2023 | 338,000.00 |